High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Explore the core reasons index funds tend to outperform active funds over the long run, focusing on fee drag, turnover impact, and diversification.
22,990 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Lawmakers warn that granting a national bank charter to a crypto-focused issuer could undermine financial integrity a...
SoFi just became first to launch a bank-issued stablecoin on a consumer app, a move that could change how people move...
Healthcare REITs offer income, but they carry unique risks. Learn how to evaluate Medical Properties Trust with actio...
Fintech down this year has pressured growth equities, yet cybersecurity ETFs are delivering relative steadiness as co...
A wave of borrowing among AI builders is reshaping how investors view growth. NVIDIA, Oracle, and SpaceX are tapping ...
In a bold move amid 13F season, investor Gavin Baker places a major levered bet on Nvidia through call options, signa...
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
A major institutional move is shaping Balchem's next chapter. As the company posts record sales, a new investor stake...
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
A SpaceX public listing could ripple across technology, energy, and investing. Learn how NuScale Power stands to gain...
A growing scam uses Bitcoin ATMs to pressure victims into sending crypto. San Antonio is posting bilingual warnings d...